Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Dipna PharmachemBOM:543594 +9.64%62 Days Payable is 354.81 as of Mar. 2026, which is 206% above its 10-year median of 115.82. GuruFocus rates BOM:543594 with a GF Score™ of 62/100 and a GF Value™ of ₹9.16 (Possible Value Trap). The stock has 9 warning signs investors should review. Among 605 Healthcare Providers & Services companies, Dipna Pharmachem ranks better than 89.42% on this metric.
The historical rank and industry rank for Dipna Pharmachem's Days Payable or its related term are showing as below:
BOM:543594'
s Days Payable Range Over the Past 10 Years
Min: 88.71 Med: 115.82 Max: 284.23
Current: 284.23
During the past 7 years, Dipna Pharmachem's highest Days Payable was 284.23. The lowest was 88.71. And the median was 115.82.
BOM:543594's Days Payable is ranked better than 89.42% of 605
companies
in the Healthcare Providers & Services industry
Industry Median: 56.95
vs BOM:543594: 284.23
Dipna Pharmachem's Days Payable
declined
from Mar. 2025 (652.49) to Mar. 2026 (354.81).
It may suggest that Dipna Pharmachemaccelerated paying its suppliers.
The historical data trend for Dipna Pharmachem's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dipna Pharmachem Days Payable Competitor Comparison
For the Pharmaceutical Retailers subindustry, Dipna Pharmachem's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dipna Pharmachem Days Payable vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Dipna Pharmachem's Days Payable distribution charts can be found below:
* The bar in red indicates where Dipna Pharmachem's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Dipna Pharmachem's Days Payable for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dipna Pharmachem (BOM:543594) has a Days Payable of 354.81 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Dipna Pharmachem and its competitors. This is 206% above median its historical median of 115.82. Over the past decade, Dipna Pharmachem's Days Payable has ranged from 88.71 to 284.23. According to the industry distribution chart, Dipna Pharmachem ranks #64 out of 605 companies in the Healthcare Providers & Services industry, placing it in the top 10.6%.
Is Dipna Pharmachem's Days Payable too high?
Dipna Pharmachem's current Days Payable of 354.81 is 206% above median its 10-year median of 115.82. Over the past 10 years, this metric has ranged from a low of 88.71 to a high of 284.23. The Healthcare Providers & Services industry median Days Payable is 56.95. Dipna Pharmachem's value of 354.81 is 523% above this industry median. Based on the distribution chart, Dipna Pharmachem ranks #64 out of 605 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Dipna Pharmachem has a GF Score™ of 62/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Dipna Pharmachem's Days Payable compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Dipna Pharmachem ranks #64 out of 605 companies for Days Payable. This places Dipna Pharmachem in the top 11% of its industry — outperforming the majority of peers. The industry median Days Payable is 56.95. Dipna Pharmachem's value of 354.81 is 523% above this benchmark. Historically, Dipna Pharmachem's own Days Payable has ranged from 88.71 to 284.23 over the past decade. While the company's 10-year median is 115.82 vs. the industry median of 56.95, Dipna Pharmachem has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Healthcare Providers & Services company?
The median Days Payable among Healthcare Providers & Services companies is 56.95, based on 605 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Dipna Pharmachem's current Days Payable of 354.81 is 523% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Dipna Pharmachem and its competitors. For the Healthcare Providers & Services industry, the median Days Payable is 56.95 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Dipna Pharmachem's current Days Payable is 354.81, which is 206% above median its own 10-year median of 115.82. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dipna Pharmachem stock overvalued right now?
Based on GuruFocus' analysis, Dipna Pharmachem (BOM:543594) is currently considered Possible Value Trap. The stock's GF Value™ is ₹9.16, compared to a current price of ₹4.89 — trading 46.6% below its estimated fair value. The current Days Payable is 354.81, which is 206% above median its 10-year median of 115.82 and 523% above the Healthcare Providers & Services industry median of 56.95. Dipna Pharmachem's overall GF Score™ is 62/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Dipna Pharmachem (BOM:543594), the current Days Payable is 354.81 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Dipna Pharmachem (BOM:543594) Overvalued in 2026?
Based on GuruFocus' analysis, Dipna Pharmachem stock appears to be undervalued.
The current stock price of ₹4.89 is trading 46.6% below its estimated GF Value™ of ₹9.16.
GuruFocus considers Dipna Pharmachem to be Possible Value Trap.
Key valuation signals for BOM:543594:
Days Payable: 354.81 (206% above median its 10-year median of 115.82)
GF Value™: ₹9.16 vs. price of ₹4.89 (46.6% below fair value)
Industry Position: 523% above the Healthcare Providers & Services median (#64 of 605)
No single metric tells the full story. See the BOM:543594 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Dipna Pharmachem Ltd is engaged in the trading and distribution of a wide range of pharmaceutical raw materials which is also known as APIs (Active Pharmaceutical Ingredients), Excipient and chemical formulation products. The company's product portfolio comprises of Hydrocortisone Acetate, Aceclofenac, Asprin, Levofloxacin, and others.
62GF Score
Get the complete analysis for BOM:543594
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:543594 has been successfully added to your 
